메뉴 건너뛰기




Volumn 27, Issue 4, 2012, Pages 1282-1284

Ongoing gaps in CKD and CVD care: Re-evaluating strategies for knowledge dissemination

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL COMPETENCE; DISEASE ASSOCIATION; EARLY INTERVENTION; EDUCATION PROGRAM; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HEALTH EDUCATION; HUMAN; HYPERTENSION; INFORMATION DISSEMINATION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; RISK REDUCTION; STRATEGIC PLANNING;

EID: 84859332671     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr765     Document Type: Article
Times cited : (4)

References (21)
  • 1
    • 79955015634 scopus 로고    scopus 로고
    • A predictive model for progression of chronic kidney disease to kidney failure
    • Tangri N, Stevens LA, Griffith J et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305: 1553-1557
    • (2011) JAMA , vol.305 , pp. 1553-1557
    • Tangri, N.1    Stevens, L.A.2    Griffith, J.3
  • 2
    • 80051569374 scopus 로고    scopus 로고
    • GFR decline and mortality risk among patients with chronic kidney disease
    • Perkins RM, Bucaloiu ID, Kirchner HL et al. GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1879-1886
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 1879-1886
    • Perkins, R.M.1    Bucaloiu, I.D.2    Kirchner, H.L.3
  • 3
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
    • (2004) N Engl J Med , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3
  • 5
    • 79957827666 scopus 로고    scopus 로고
    • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease.A collaborative meta-analysis of kidney disease population cohorts
    • Astor BA, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
    • (2011) Kidney Int , vol.79 , pp. 1331-1340
    • Astor, B.A.1    Matsushita, K.2    Gansevoort, R.T.3
  • 6
    • 79958811114 scopus 로고    scopus 로고
    • The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report
    • Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28
    • (2011) Kidney Int , vol.80 , pp. 17-28
    • Levey, A.S.1    De Jong, P.E.2    Coresh, J.3
  • 7
    • 52049096629 scopus 로고    scopus 로고
    • Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort
    • Levin A, Djurdjev O, BeaulieuMet al. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008; 52: 661-671
    • (2008) Am J Kidney Dis , vol.52 , pp. 661-671
    • Levin, A.1    Djurdjev, O.2    Beaulieu, M.3
  • 8
    • 56649086676 scopus 로고    scopus 로고
    • Guidelines for the management of chronic kidney disease
    • Levin A, Hemmelgarn B, Culleton B et al. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179: 1154-1162
    • (2008) CMAJ , vol.179 , pp. 1154-1162
    • Levin, A.1    Hemmelgarn, B.2    Culleton, B.3
  • 9
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation classification, and stratification
    • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.AmJKidneyDis 2002; 39: S1-S266
    • (2002) Am J Kidney Dis , vol.39
  • 10
    • 75849147039 scopus 로고    scopus 로고
    • Relation between kidney function, proteinuria, and adverse outcomes
    • Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429
    • (2010) JAMA , vol.303 , pp. 423-429
    • Hemmelgarn, B.R.1    Manns, B.J.2    Lloyd, A.3
  • 13
    • 1642413198 scopus 로고    scopus 로고
    • Longitudinal Follow-up and Outcomes among a Population with Chronic Kidney Disease in a Large Managed Care Organization
    • DOI 10.1001/archinte.164.6.659
    • Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663 (Pubitemid 38392981)
    • (2004) Archives of Internal Medicine , vol.164 , Issue.6 , pp. 659-663
    • Keith, D.S.1    Nichols, G.A.2    Gullion, C.M.3    Brown, J.B.4    Smith, D.H.5
  • 15
    • 42449159875 scopus 로고    scopus 로고
    • Limited knowledge of kidney disease in a survey of AusDiab study participants
    • White SL, Polkinghorne KR, Cass A et al. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008; 188: 204-208
    • (2008) Med J Aust , vol.188 , pp. 204-208
    • White, S.L.1    Polkinghorne, K.R.2    Cass, A.3
  • 16
    • 27844597274 scopus 로고    scopus 로고
    • Barriers to successful care for chronic kidney disease
    • Lenz O, Mekala DP, Patel DV et al. Barriers to successful care for chronic kidney disease. BMC Nephrol 2005; 6: 11 17.
    • (2005) BMC Nephrol , vol.6 , pp. 1117
    • Lenz, O.1    Mekala, D.P.2    Patel, D.V.3
  • 18
  • 20
    • 38049096095 scopus 로고    scopus 로고
    • The meaning of translational research and why it matters
    • Woolf SH. The meaning of translational research and why it matters. JAMA 2008; 299: 211-213
    • (2008) JAMA , vol.299 , pp. 211-213
    • Woolf, S.H.1
  • 21
    • 79959746706 scopus 로고    scopus 로고
    • On behalf of the SHARP Investigators.The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): Randomised placebo-controlled trial
    • Baigent C, Landray MJ, Reith C et al. on behalf of the SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192
    • (2011) Lancet , vol.377 , pp. 2181-2192
    • Baigent, C.1    Landray, M.J.2    Reith, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.